Patents by Inventor Ulrik Svane

Ulrik Svane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potassium channel inhibitors
    Patent number: 11274092
    Abstract: The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: March 15, 2022
    Assignee: ACESION PHARMA ApS
    Inventors: Ulrik Svane Sørensen, Antonio Mete
  • Potassium channel inhibitors
    Patent number: 11168074
    Abstract: A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: November 9, 2021
    Assignee: ACESION PHARMA ApS
    Inventors: Ulrik Svane Sørensen, Antonio Mete
  • Potassium channel inhibitors
    Patent number: 11098018
    Abstract: A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: August 24, 2021
    Assignee: ACESION PHARMA ApS
    Inventors: Ulrik Svane Sørensen, Antonio Mete
  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20210188804
    Abstract: The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 24, 2021
    Applicant: ACESION PHARMA ApS
    Inventors: Ulrik Svane SØRENSEN, Antonio METE
  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20200255409
    Abstract: A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Application
    Filed: August 22, 2018
    Publication date: August 13, 2020
    Applicant: ACESION PHARMA ApS
    Inventors: Ulrik Svane SØRENSEN, Antonio METE
  • NOVEL POTASSIUM CHANNEL INHIBITORS
    Publication number: 20200216398
    Abstract: A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
    Type: Application
    Filed: August 13, 2018
    Publication date: July 9, 2020
    Applicant: ACESION PHARMA ApS
    Inventors: Ulrik Svane SØRENSEN, Antonio METE
  • Purinyl derivatives and their use as potassium channel modulators
    Patent number: 9340544
    Abstract: This invention relates to novel purinyl derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: May 17, 2016
    Assignee: ATAXION, INC.
    Inventors: Birgitte L. Eriksen, Ulrik Svane Sørensen, Charlotte Hougaard, Dan Peters, Tina Holm Johansen, Palle Christophersen
  • Pharmaceutical Compositions for Combination Therapy
    Publication number: 20150164871
    Abstract: This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective amount of a sodium channel inhibitor, in a combination with a small-conductance calcium-activated potassium (SK) channel inhibitor, for the treatment of cardiac arrhythmias.
    Type: Application
    Filed: June 13, 2013
    Publication date: June 18, 2015
    Applicant: Acesion Pharma
    Inventors: Morten Grunnet, Ulrik Svane Sørensen, Bo Hjorth Bentzen, Jonas Goldin Diness
  • Substituted [1,2,4]triazolo[1,5-]pyrimidines and their use as potassium channel modulators
    Patent number: 8765770
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: July 1, 2014
    Assignee: Ataxion, Inc.
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dotre Strøbæk, Palle Christophersen
  • Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
    Patent number: 8685987
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 1, 2014
    Assignee: Ataxion, Inc.
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbæk, Palle Christophersen
  • Pyrazine derivatives and their use as potassium channel modulators
    Patent number: 8415358
    Abstract: Pyrazine compounds of the formula as well as stereoisomers thereof, N-oxides thereof, prodrugs thereof, and pharmaceutically acceptable salts thereof, wherein the variables in the formula are as defined in the specification. The compounds are useful as potassium channel modulating agents. Also, pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, and methods of using the pharmaceutical compositions.
    Type: Grant
    Filed: September 16, 2008
    Date of Patent: April 9, 2013
    Assignee: Neurosearch A/S
    Inventors: Birgitte L. Eriksen, Ulrik Svane Sørensen, Charlotte Hougaard, Dan Peters, Palle Christophersen
  • Purinyl derivatives and their use as potassium channel modulators
    Patent number: 8362024
    Abstract: This invention relates to novel purinyl derivatives of formula Ia or Ib Wherein the symbols are as defined in the Specification and of pharmaceutically acceptable salts thereof useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: January 29, 2013
    Assignee: NeuroSearch A/S
    Inventors: Birgitte L. Eriksen, Ulrik Svane Sørensen, Charlotte Hougaard, Dan Peters, Tina Holm Johansen, Palle Christophersen
  • Potassium channel modulating agents and their medical use
    Patent number: 8252806
    Abstract: This invention relates to novel potassium channel modulating agents, and their use in the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: August 28, 2012
    Assignee: Neurosearch A/S
    Inventors: Birgitte L. Eriksen, Lene Teuber, Charlotte Hougaard, Ulrik Svane Sørensen
  • Indazolyl derivatives useful as potassium channel modulating agents
    Patent number: 8222262
    Abstract: Potassium channel modulating agents of Formula Ia or Ib and enantiomers and mixtures enantiomers and N-oxides thereof, and pharmaceutically acceptable salts thereof, and their use in the preparation of pharmaceutical compositions. Also, pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, e.g.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: July 17, 2012
    Assignee: Neurosearch A/S
    Inventors: Birgitte L. Eriksen, Ulrik Svane Sørensen, Charlotte Hougaard, Lene Teuber, Dan Peters, Palle Christophersen, Tina Holm Johansen
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120101112
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: March 30, 2010
    Publication date: April 26, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbæk, Palle Christophersen
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120095025
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines useful as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. Formula (I).
    Type: Application
    Filed: March 30, 2010
    Publication date: April 19, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Dorte Strøbæk, Palle Christophersen
  • SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120088780
    Abstract: This invention relates to novel substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as modulators of potassium channels. In other aspects the invention relates to the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Application
    Filed: March 30, 2010
    Publication date: April 12, 2012
    Applicant: NEUROSEARCH A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Charlotte Hougaard, Dorte Strøbaek, Palle Christophersen
  • PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
    Publication number: 20120004246
    Abstract: This invention relates to novel purinyl derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels.
    Type: Application
    Filed: March 27, 2008
    Publication date: January 5, 2012
    Applicant: NeuroSearch A/S
    Inventors: Birgitte L. Eriksen, Ulrik Svane Sorensen, Charlotte Hougaard, Dan Peters, Palle Christophersen
  • Guanidine derivatives and their medical use
    Patent number: 8048877
    Abstract: This invention relates to novel guanidine derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: November 1, 2011
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Palle Christophersen
  • 2-aminio-pyridine derivatives and their use as potassium channel modulators
    Patent number: 8039632
    Abstract: This invention relates to novel 2-amino-pyridine derivative useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: October 18, 2011
    Assignee: Neurosearch A/S
    Inventors: Ulrik Svane Sørensen, Birgitte L. Eriksen, Lene Teuber, Dan Peters, Dorte Strøbæk, Tina Holm Johansen, Palle Christophersen